DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Chen J, Florian J, Carter W. , et al.
Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies.
Gastroenterology 2013;
144 (07) 1450-1455.e2
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.